Chimin Health Management Co., Ltd. (SHA:603222)
China flag China · Delayed Price · Currency is CNY
7.78
0.00 (0.00%)
Sep 14, 2026, 3:00 PM CST

Chimin Health Management Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
653.59682.77768.99891.24835.221,095
Other Revenue
3.563.196.743.272.023.86
657.15685.96775.73894.51837.241,098
Revenue Growth
-2.86%-11.57%-13.28%6.84%-23.78%25.16%
Cost of Revenue
486.8517.62496.13515.7451.04572.59
Gross Profit
170.35168.35279.6378.81386.2525.88
Selling, General & Admin
236.3251.04276.71293.6258.96268.9
Research & Development
54.4747.9241.6128.928.3830
Other Operating Expenses
9.8510.096.929.9611.6413.64
Operating Expenses
306.15318.81321.66341.92299.92316.72
Operating Income
-135.8-150.47-42.0636.8986.28209.16
Interest Expense
-24.56-23.99-21.03-23.11-27.42-35.24
Interest & Investment Income
1.552.524.248.3711.9740.87
Currency Exchange Gain (Loss)
-2.72-1.881.10.625.41-1.63
Other Non Operating Income (Expenses)
-1.98-1.31-1.53-52.21-36.24-29.15
EBT Excluding Unusual Items
-163.51-175.12-59.28-29.4340184.02
Impairment of Goodwill
-20.39-20.39--22.34-10.08-13.09
Gain (Loss) on Sale of Investments
-0-0.01----2.76
Gain (Loss) on Sale of Assets
-0.38-0.29-1.73-1.67-0.24-6.38
Asset Writedown
-13.18-13.18----
Legal Settlements
-24.85-24.85---11.27
Other Unusual Items
-1.94-0.11-5.454.2813.251.42
Pretax Income
-224.25-233.95-66.46-49.1642.94174.48
Income Tax Expense
23.5712.87-10.330.0416.8236.43
Earnings From Continuing Operations
-247.82-246.82-56.13-49.226.12138.05
Minority Interest in Earnings
5.511.24-3.58-16.288.339.47
Net Income
-242.31-245.58-59.71-65.4834.46147.52
Net Income to Common
-242.31-245.58-59.71-65.4834.46147.52
Net Income Growth
-----76.64%2206.02%
Shares Outstanding (Basic)
506523543546492476
Shares Outstanding (Diluted)
506523543546492476
Shares Change
-8.28%-3.74%-0.52%10.86%3.43%6.37%
EPS (Basic)
-0.48-0.47-0.11-0.120.070.31
EPS (Diluted)
-0.48-0.47-0.11-0.120.070.31
EPS Growth
-----77.42%2067.83%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-13.83-56.57-49.03-9.028.54-7.25
Free Cash Flow Per Share
-0.03-0.11-0.09-0.020.02-0.01
Dividend Per Share
----0.0200.064
Dividend Growth
-----68.90%-
Gross Margin
25.92%24.54%36.04%42.35%46.13%47.87%
Operating Margin
-20.66%-21.93%-5.42%4.12%10.31%19.04%
Profit Margin
-36.87%-35.80%-7.70%-7.32%4.12%13.43%
Free Cash Flow Margin
-2.10%-8.25%-6.32%-1.01%1.02%-0.66%
EBITDA
-39.26-51.4859.19127.17161.17287.55
EBITDA Margin
-5.97%-7.50%7.63%14.22%19.25%26.18%
D&A For EBITDA
96.5498.99101.2590.2774.8978.39
EBIT
-135.8-150.47-42.0636.8986.28209.16
EBIT Margin
-20.66%-21.93%-5.42%4.12%10.31%19.04%
Effective Tax Rate
----39.17%20.88%
Revenue as Reported
657.15685.96775.73894.51837.241,098
Advertising Expenses
-114.56126.41146.44132.09144.76